Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
CorMedix
CRMD
$605M
| $311K | ﹤0.01% |
73,600
+60,000
| +441% | +$212K |
|
3202
PEDEVCO
PED
$170M
| $311K | ﹤0.01% |
14,145
-13,815
| -49% | -$321K |
|
3203
Stock Yards Bancorp
SYBT
$2.64B
| $311K | ﹤0.01% |
4,790
+100
| +2% | +$7.15K |
|
3204
Krispy Kreme
DNUT
$604M
| $309K | ﹤0.01% |
+29,900
| New | +$407K |
|
3205
KFA Mount Lucas Managed Futures Index Strategy ETF
KMLM
$417M
| $309K | ﹤0.01% |
+10,100
| New | +$362K |
|
3206
Direxion Daily Retail Bull 3X ETF
RETL
$27.4M
| $309K | ﹤0.01% |
44,400
-21,226
| -32% | -$165K |
|
3207
Protalix BioTherapeutics
PLX
$183M
| $308K | ﹤0.01% |
224,603
+107,403
| +92% | +$118K |
|
|
JNCE
3208
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $307K | ﹤0.01% |
276,896
+197,196
| +247% | +$281K |
|
3209
Donaldson
DCI
$11.1B
| $306K | ﹤0.01% |
5,200
-50,500
| -91% | -$2.89M |
|
3210
Vor Biopharma
VOR
$1.35B
| $306K | ﹤0.01% |
2,298
+703
| +44% | +$69.6K |
|
|
TBHC
3211
DELISTED
The Brand House Collective
TBHC
| $304K | ﹤0.01% |
92,100
-31,300
| -25% | -$115K |
|
3212
PrimeEnergy Resources
PNRG
$320M
| $304K | ﹤0.01% |
3,500
+200
| +6% | +$16.1K |
|
3213
ARK Innovation ETF
ARKK
$6.43B
| $303K | ﹤0.01% |
+9,700
| New | +$347K |
|
3214
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
| $303K | ﹤0.01% |
+13,500
| New | +$293K |
|
3215
Better Online Solutions
BOSC
$32.4M
| $302K | ﹤0.01% |
144,511
-15,584
| -10% | -$34.6K |
|
3216
Cooper-Standard Automotive
CPS
$501M
| $301K | ﹤0.01% |
33,200
+8,900
| +37% | +$63K |
|
|
RENT
3217
Rent the Runway
RENT
$119M
| $301K | ﹤0.01% |
4,940
+3,700
| +298% | +$150K |
|
3218
Bristow Group
VTOL
$1.38B
| $301K | ﹤0.01% |
11,100
-1,000
| -8% | -$26.1K |
|
3219
Abercrombie & Fitch
ANF
$4.83B
| $300K | ﹤0.01% |
13,100
-42,300
| -76% | -$833K |
|
3220
Bakkt Inc
BKKT
$334M
| $300K | ﹤0.01% |
10,068
+312
| +3% | +$14.6K |
|
3221
Corporacion America
CAAP
$6.37B
| $299K | ﹤0.01% |
+34,200
| New | +$277K |
|
3222
HBT Financial
HBT
$1.35B
| $299K | ﹤0.01% |
15,300
-2,800
| -15% | -$55.1K |
|
3223
iShares Russell Mid-Cap ETF
IWR
$58.4B
| $297K | ﹤0.01% |
4,400
-2,300
| -34% | -$155K |
|
3224
Palladyne AI
PDYN
$326M
| $297K | ﹤0.01% |
+88,069
| New | +$751K |
|
3225
FRP Holdings
FRPH
$426M
| $296K | ﹤0.01% |
11,000
+200
| +2% | +$5.71K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.